HK1189498A1 - 放射性標記的基於苯基咪唑的配體 - Google Patents

放射性標記的基於苯基咪唑的配體

Info

Publication number
HK1189498A1
HK1189498A1 HK14102645.9A HK14102645A HK1189498A1 HK 1189498 A1 HK1189498 A1 HK 1189498A1 HK 14102645 A HK14102645 A HK 14102645A HK 1189498 A1 HK1189498 A1 HK 1189498A1
Authority
HK
Hong Kong
Prior art keywords
phenylimidazole
radiolabelled
based ligands
ligands
radiolabelled phenylimidazole
Prior art date
Application number
HK14102645.9A
Other languages
English (en)
Inventor
Jan Kehler
Benny Bang-Andersen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of HK1189498A1 publication Critical patent/HK1189498A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK14102645.9A 2010-11-10 2014-03-17 放射性標記的基於苯基咪唑的配體 HK1189498A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41193410P 2010-11-10 2010-11-10
DKPA201001023 2010-11-10
PCT/DK2011/000132 WO2012062319A1 (en) 2010-11-10 2011-11-10 Radiolabelled phenylimidazole-based ligands

Publications (1)

Publication Number Publication Date
HK1189498A1 true HK1189498A1 (zh) 2014-06-13

Family

ID=45098760

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14102645.9A HK1189498A1 (zh) 2010-11-10 2014-03-17 放射性標記的基於苯基咪唑的配體

Country Status (19)

Country Link
US (1) US8592449B1 (zh)
EP (1) EP2637704B9 (zh)
JP (1) JP5820887B2 (zh)
CN (1) CN103732260B (zh)
AU (1) AU2011328598B2 (zh)
CA (1) CA2817385A1 (zh)
DK (1) DK2637704T5 (zh)
ES (1) ES2539464T3 (zh)
HK (1) HK1189498A1 (zh)
HR (1) HRP20150560T2 (zh)
HU (1) HUE025511T2 (zh)
ME (1) ME02145B (zh)
PL (1) PL2637704T3 (zh)
PT (1) PT2637704E (zh)
RS (1) RS54039B1 (zh)
SG (1) SG190686A1 (zh)
SI (1) SI2637704T1 (zh)
SM (1) SMT201500139B (zh)
WO (1) WO2012062319A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9790203B2 (en) 2012-11-26 2017-10-17 Abbvie Inc. Inhibitor compounds of phosphodiesterase type 10A
US20150313884A1 (en) 2013-01-15 2015-11-05 Novartis Ag Use of alpha 7 nicotinic acetylcholine receptor agonists
KR101879920B1 (ko) * 2013-01-15 2018-07-18 노파르티스 아게 알파 7 니코틴성 아세틸콜린 수용체 작용물질의 용도
CA2899781A1 (en) * 2013-01-31 2014-08-07 F.Hoffmann-La Roche Ag Radiolabeled compounds
TW202031250A (zh) 2018-11-06 2020-09-01 丹麥商Ｈ 朗德貝克公司 用於治療負性症狀和認知損傷之pde10a抑制劑

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0425548D0 (en) 2004-11-19 2004-12-22 Glaxo Group Ltd Radiolabelled ligands
WO2006075226A1 (en) 2005-01-13 2006-07-20 Pfizer Products Inc. 11c-labeled benzyl-lactam compounds and their use as imaging agents
WO2008020302A2 (en) 2006-08-17 2008-02-21 Pfizer Products Inc. Heteroaromatic quinoline-based compounds as phosphodiesterase (pde) inhibitors
EP2036578A1 (en) 2007-09-13 2009-03-18 Bayer Schering Pharma Aktiengesellschaft Diagnostic agents for positron emission imaging using F-18 radio labeled amino-alcohols
TWI501965B (zh) * 2008-06-20 2015-10-01 Lundbeck & Co As H 作為ｐｄｅ１０ａ酵素抑制劑之新穎苯基咪唑衍生物
WO2010097367A1 (en) 2009-02-24 2010-09-02 Janssen Pharmaceutica Nv Radiolabelled pde10 ligands

Also Published As

Publication number Publication date
WO2012062319A1 (en) 2012-05-18
EP2637704A1 (en) 2013-09-18
US8592449B1 (en) 2013-11-26
PT2637704E (pt) 2015-07-21
CN103732260B (zh) 2018-08-10
EP2637704B1 (en) 2015-03-25
JP2013543851A (ja) 2013-12-09
EP2637704B9 (en) 2015-08-05
HRP20150560T1 (en) 2015-07-03
SG190686A1 (en) 2013-07-31
DK2637704T5 (en) 2015-09-21
PL2637704T4 (pl) 2015-08-31
DK2637704T3 (da) 2015-06-22
AU2011328598B2 (en) 2016-04-21
SI2637704T1 (sl) 2015-07-31
RS54039B1 (en) 2015-10-30
HUE025511T2 (en) 2016-04-28
AU2011328598A1 (en) 2013-05-30
CA2817385A1 (en) 2012-05-18
US20130303770A1 (en) 2013-11-14
ME02145B (me) 2015-10-20
PL2637704T3 (pl) 2015-08-31
HRP20150560T2 (hr) 2015-11-20
CN103732260A (zh) 2014-04-16
SMT201500139B (it) 2015-09-07
ES2539464T3 (es) 2015-07-01
JP5820887B2 (ja) 2015-11-24

Similar Documents

Publication Publication Date Title
DK3342786T3 (en) Anti-dll3-antistof
AP3107A (en) 5-Alkynyl-pyrimidines
IL221416A0 (en) Alpha-emititng complexes
EP2566479A4 (en) AZA-INDAZOLES
EP2640189A4 (en) 3-deutero-pomalidomide
PT2585216T (pt) Complexos de п-alilpaládio e п-alilníquel para utilização como catalisadores em reações de acoplamento de carbono-carbono e carbono-azoto
DK3466977T3 (en) Anti-vla-4-antistoffer
EP2516407A4 (en) RADIOPHARMACEUTICAL COMPLEXES
EP2651505A4 (en) ELECTROPORATION-INDUCED ELECTROSENSIBILIZATION
EP2641891A4 (en) PKC ACTIVATOR-
EP2548959A4 (en) FLORIGENIC ACTIVATOR COMPLEX
ZA201204448B (en) Heavy-duty axle-to-beam connection
GB201002397D0 (en) Carrier selection
HK1173368A1 (zh) 色素沉着預防或改善劑
IL219423A0 (en) Radiolabelled pde10 ligands
HRP20150560T1 (en) Radiolabelled phenylimidazole-based ligands
GB201003483D0 (en) Gold complexes
GB201004151D0 (en) Luminophores
GB201010960D0 (en) Complex
EP2640832A4 (en) NEW ETHIOLOGICAL AGENT
GB201118411D0 (en) Not available
GB0901231D0 (en) Ligands
AU4536P (en) TB01 Tibouchina urvilleana
AU4937P (en) FlatinsulGL Myoporum insulare
AU4822P (en) FlatwaxwhiteGL Chamelaucium uncinatum

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20191114